73
Views
40
CrossRef citations to date
0
Altmetric
Articles

Immunomodulating Activity of Rifampicin

Pages 357-361 | Published online: 18 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Ya-Chu Tsai & Tsen-Fang Tsai. (2019) A review of antibiotics and psoriasis: induction, exacerbation, and amelioration. Expert Review of Clinical Pharmacology 12:10, pages 981-989.
Read now
Nikolai Tsankov & Ivan Grozdev. (2011) Rifampicin – A mild immunosuppressive agent for psoriasis. Journal of Dermatological Treatment 22:2, pages 62-64.
Read now
Na An, Yu Song, Xuemei Zhang, Xinxin Ci, Hongyu Li, Yongguo Cao, Mohan Zhang, Junqing Cui & Xuming Deng. (2008) Pretreatment of Mice with Rifampicin Prolongs Survival of Endotoxic Shock by Modulating the Levels of Inflammatory Cytokines. Immunopharmacology and Immunotoxicology 30:3, pages 437-446.
Read now
Nikolai Tsankov, Ivan Grozdev & Jana Kkzandjieva. (2006) Old drug – new indication. Rifampicin in psoriasis. Journal of Dermatological Treatment 17:1, pages 18-23.
Read now
Marie-Thérèse Labro. (2005) Anti-inflammatory activity of ansamycins. Expert Review of Anti-infective Therapy 3:1, pages 91-103.
Read now

Articles from other publishers (35)

Simisola Ayodele, Pradeep Kumar, Armorel van Eyk & Yahya E. Choonara. (2023) Advances in immunomodulatory strategies for host-directed therapies in combating tuberculosis. Biomedicine & Pharmacotherapy 162, pages 114588.
Crossref
Vo Thuy Anh Thu, Ly Da Dat, Rannissa Puspita Jayanti, Hoang Kim Tu Trinh, Tran Minh Hung, Yong-Soon Cho, Nguyen Phuoc Long & Jae-Gook Shin. (2023) Advancing personalized medicine for tuberculosis through the application of immune profiling. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Tong-Rong Jan, Chen-Si Lin, Sheng-Yao Wang & Wen-Yuan Yang. (2023) Cytokines and cecal microbiome modulations conferred by a dual vaccine in Salmonella-infected layers. Poultry Science 102:2, pages 102373.
Crossref
Chantal M. Wallenwein, Mukul Ashtikar, Götz Hofhaus, Isabel Haferland, Manuela Thurn, Anke König, Andreas Pinter, Jennifer Dressman & Matthias G. Wacker. (2023) How wound environments trigger the release from Rifampicin-loaded liposomes. International Journal of Pharmaceutics 633, pages 122606.
Crossref
Isabel Haferland, Chantal M. Wallenwein, Tanja Ickelsheimer, Sandra Diehl, Matthias G. Wacker, Susanne Schiffmann, Claudia Buerger, Roland Kaufmann, Anke Koenig & Andreas Pinter. (2022) Mechanism of anti‐inflammatory effects of rifampicin in an ex vivo culture system of hidradenitis suppurativa. Experimental Dermatology 31:7, pages 1005-1013.
Crossref
Juan Pablo Rigalli, Dirk Theile, Julie Nilles & Johanna Weiss. (2021) Regulation of PXR Function by Coactivator and Corepressor Proteins: Ligand Binding Is Just the Beginning. Cells 10:11, pages 3137.
Crossref
Christina Cahill, Dónal J. Cox, Fiona O’Connell, Sharee A. Basdeo, Karl M. Gogan, Cilian Ó’Maoldomhnaigh, Jacintha O’Sullivan, Joseph Keane & James J. Phelan. (2021) The Effect of Tuberculosis Antimicrobials on the Immunometabolic Profiles of Primary Human Macrophages Stimulated with Mycobacterium tuberculosis. International Journal of Molecular Sciences 22:22, pages 12189.
Crossref
Reşit Yıldırım, Döndü Üsküdar Cansu, Burcu Ceren Ekti Uludoğan, Mustafa Dinler, Emel Tekin & Cengiz Korkmaz. (2021) The coexistence of IgA vasculitis and tuberculosis: a case-based review. Rheumatology International 41:9, pages 1683-1689.
Crossref
Hyun-Eui Park, Wonsik Lee, Min-Kyoung Shin & Sung Jae Shin. (2021) Understanding the Reciprocal Interplay Between Antibiotics and Host Immune System: How Can We Improve the Anti-Mycobacterial Activity of Current Drugs to Better Control Tuberculosis?. Frontiers in Immunology 12.
Crossref
K.R. van Straalen, S. Schneider‐Burrus & E.P. Prens. (2018) Current and future treatment of hidradenitis suppurativa. British Journal of Dermatology 183:6.
Crossref
Christina Cahill, James Joseph Phelan & Joseph Keane. (2020) Understanding and Exploiting the Effect of Tuberculosis Antimicrobials on Host Mitochondrial Function and Bioenergetics. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Yi-Tei Wu, Wen-Yuan Yang, Yi-Hsieng Samuel Wu, Jr-Wei Chen & Yi-Chen Chen. (2020) Modulations of growth performance, gut microbiota, and inflammatory cytokines by trehalose on Salmonella Typhimurium-challenged broilers. Poultry Science 99:8, pages 4034-4043.
Crossref
Hamid Zahednasab, Masoumeh Firouzi, Sussan Kaboudanian-Ardestani, Zahra Mojallal-Tabatabaei, Sajad Karampour & Hossein Keyvani. (2019) The protective effect of rifampicin on behavioral deficits, biochemical, and neuropathological changes in a cuprizone model of demyelination. Cytokine 113, pages 417-426.
Crossref
Allard R. J. V. Vossen, Hessel H. van der Zee & Errol P. Prens. (2018) Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model. Frontiers in Immunology 9.
Crossref
Döndü Üsküdar Cansu, Nilgün Işıksalan Özbülbül, Gülsüm Akyol, Deniz Arık & Cengiz Korkmaz. (2018) Do pulmonary findings of granulomatosis with polyangiitis respond to anti-tuberculosis treatment?. Rheumatology International 38:6, pages 1131-1138.
Crossref
Seung Hyun Kim, Ki Man Lee, Geum Seon Lee, Ju-Won Seong & Tae Jin Kang. (2017) Rifampicin Alleviates Atopic Dermatitis-Like Response in vivo and in vitro . Biomolecules & Therapeutics 25:6, pages 634-640.
Crossref
Ahmed Shah, Raed Alhusayen & Saeid Amini-Nik. (2017) The critical role of macrophages in the pathogenesis of hidradenitis suppurativa. Inflammation Research 66:11, pages 931-945.
Crossref
C. Dessinioti, C. Zisimou, V. Tzanetakou, A. Stratigos & C. Antoniou. (2016) Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up. Clinical and Experimental Dermatology 41:8, pages 852-857.
Crossref
Yan Liang, Xuejuang Bai, Junxian Zhang, Jingying Song, Yourong Yang, Qi Yu, Ning Li & Xueqiong Wu. (2016) Ag85A/ESAT-6 chimeric DNA vaccine induces an adverse response in tuberculosis-infected mice. Molecular Medicine Reports.
Crossref
I. E. Deckers & E. P. Prens. (2015) An Update on Medical Treatment Options for Hidradenitis Suppurativa. Drugs 76:2, pages 215-229.
Crossref
Iben Marie Miller, Hans Christian Ring, Errol P. Prens, Helene Rytgaard, Ulla B. Mogensen, Christina Ellervik & Gregor B.E. Jemec. (2016) Leukocyte Profile in Peripheral Blood and Neutrophil-Lymphocyte Ratio in Hidradenitis Suppurativa: A Comparative Cross-Sectional Study of 462 Cases. Dermatology 232:4, pages 511-519.
Crossref
Melanie Jane Maslow & Cynthia Portal-Celhay. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 339 349.e3 .
Claudia Manca, Mi-Sun Koo, Blas Peixoto, Dorothy Fallows, Gilla Kaplan & Selvakumar Subbian. (2013) Host Targeted Activity of Pyrazinamide in Mycobacterium tuberculosis Infection. PLoS ONE 8:8, pages e74082.
Crossref
Caridad Rosette, Fernando Buendia-LaysaJr.Jr., Seema Patkar, Luigi Moro, Giuseppe Celasco, Roberta Bozzella, Mauro Ajani & Mara Gerloni. (2013) Anti-inflammatory and immunomodulatory activities of rifamycin SV. International Journal of Antimicrobial Agents 42:2, pages 182-186.
Crossref
Xiaohui Wang, Peter M. Grace, Michael N. Pham, Kui Cheng, Keith A. Strand, Christina Smith, Jing Li, Linda R. Watkins & Hang Yin. (2013) Rifampin inhibits Toll‐like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain. The FASEB Journal 27:7, pages 2713-2722.
Crossref
Yael Yuhas, Eva Berent & Shai Ashkenazi. (2011) Effect of Rifampin on Production of Inflammatory Mediators in HepG2 Liver Epithelial Cells. Antimicrobial Agents and Chemotherapy 55:12, pages 5541-5546.
Crossref
Wei Bi, Lihong Zhu, Chuanming Wang, Yanran Liang, Jun Liu, Qiaoyun Shi & Enxiang Tao. (2011) Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation. Brain Research 1395, pages 12-20.
Crossref
Younes Smani, Juan Domínguez-Herrera & Jerónimo Pachón. (2011) Rifampin Protects Human Lung Epithelial Cells Against Cytotoxicity Induced by Clinical Multi and Pandrug-resistant Acinetobacter baumannii. The Journal of Infectious Diseases 203:8, pages 1110-1119.
Crossref
Sandrine Dubrac, Andreas Elentner, Susanne Ebner, Jutta Horejs-Hoeck & Matthias Schmuth. (2010) Modulation of T Lymphocyte Function by the Pregnane X Receptor. The Journal of Immunology 184:6, pages 2949-2957.
Crossref
KAZUHIRO KATAOKA, YUTAKA KONO, MASANOBU SUGIMOTO, YASUHIRO FURUICHI, MASAYOSHI SHICHIRI & YUJIRO TANAKA. (2010) Hepatocyte-protective and anti-oxidant effects of rifampicin on human chronic hepatitis C and murine acute hepatocyte disorder. Experimental and Therapeutic Medicine 1:6, pages 1041-1047.
Crossref
Yael Yuhas, Eva Berent, Regev Cohen & Shai Ashkenazi. (2009) Roles of NF-κB Activation and Peroxisome Proliferator-Activated Receptor Gamma Inhibition in the Effect of Rifampin on Inducible Nitric Oxide Synthase Transcription in Human Lung Epithelial Cells. Antimicrobial Agents and Chemotherapy 53:4, pages 1539-1545.
Crossref
N Tsankov & I Grozdev. (2009) Rifampicin in the treatment of psoriasis. Journal of the European Academy of Dermatology and Venereology 23:1, pages 93-95.
Crossref
Oscar Cirioni, Carmela Silvestri, Roberto Ghiselli, Fiorenza Orlando, Alessandra Riva, Federico Mocchegiani, Leonardo Chiodi, Sefora Castelletti, Eleonora Gabrielli, Vittorio Saba, Giorgio Scalise & Andrea Giacometti. (2008) Protective effects of the combination of α-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. Journal of Antimicrobial Chemotherapy 62:6, pages 1332-1338.
Crossref
Yuichi Chikaraishi, Nozomu Matsunaga, Masamitsu Shimazawa & Hideaki Hara. (2008) Rifampicin inhibits the retinal neovascularization in vitro and in vivo. Experimental Eye Research 86:1, pages 131-137.
Crossref
Yael Yuhas, Inbar Azoulay-Alfaguter, Eva Berent & Shai Ashkenazi. (2007) Rifampin Inhibits Prostaglandin E 2 Production and Arachidonic Acid Release in Human Alveolar Epithelial Cells . Antimicrobial Agents and Chemotherapy 51:12, pages 4225-4230.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.